Aarti Drugs Ltd. - Research Center
524348 AARTIDRUGS Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 20 | Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Sales | 990.71 | 822.18 | 812.73 | 671.06 | 517.26 |
| Operating profit | 225.07 | 126.90 | 117.51 | 95.87 | 77.22 |
| Interest | 13.37 | 15.32 | 16.88 | 17.97 | 16.06 |
| Gross profit | 213.20 | 112.32 | 100.95 | 78.94 | 61.30 |
| EPS (Rs) | 15.32 | 35.76 | 22.48 | 17.14 | 11.99 |
Half yearly
results in details
| Sep ' 20 | Mar ' 20 | Sep ' 19 | Sep ' 18 | Sep ' 17 | |
|---|---|---|---|---|---|
| Other income | 1.50 | 0.74 | 0.32 | 1.04 | 0.14 |
| Stock adjustment | -6.66 | -21.99 | -31.94 | -11.27 | -36.38 |
| Raw material | 581.14 | 531.55 | 547.25 | 443.58 | 348.30 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 35.24 | 30.98 | 29.12 | 25.81 | 24.25 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 155.92 | 154.74 | 150.79 | 117.07 | 103.87 |
| Provisions made | - | - | - | - | - |
| Depreciation | 23.89 | 23.84 | 22.83 | 19.87 | 18.75 |
| Taxation | 46.50 | 13.55 | 25.75 | 18.65 | 13.95 |
| Net profit / loss | 142.81 | 83.31 | 52.37 | 40.42 | 28.60 |
| Extra ordinary item | - | 8.38 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 93.20 | 23.30 | 23.30 | 23.58 | 23.86 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 22.72 | 15.43 | 14.46 | 14.29 | 14.93 |
| GPM (%) | 21.49 | 13.65 | 12.42 | 11.75 | 11.85 |
| NPM (%) | 14.39 | 10.12 | 6.44 | 6.01 | 5.53 |
© 2021 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis